News
Psychedelics for Serious Illness: An update on the state of science for psychedelics, and what all clinicians should know as they enter this uncharted territory.
Landmark Petition to Reschedule Psilocybin filed with DEA
Bipartisan Congressional Lawmakers Tell DEA To Allow Psilocybin Treatment For Terminal Patients
AIMS Social Equity Entheogenic Care Partnership
AIMS Co-Director Dr. Sunil Aggarwal Named Fellow of the American Academy of Hospice and Palliative Medicine
The Well-being Wave in Public Health–Dr. Aggarwal’s Addresses End of Life Washington.
Dr. Aggarwal Interviewed after AIMS v. DEA Ninth Circuit Court Hearing
Ketamine-assisted Psychotherapy / AIMS vs. DEA – Part 1
GW Integrative Medicine Podcast
Malani S, Brown M, Streufert J, Aggarwal SK. Cannabinoids. In A.M. Berger and J. O’Neill. (Eds.), Pediatric and Adult Palliative Care and Support Oncology, 5th Edition Wolters Kluwer. 2021.
AIMS v. US DEA
Integrative and Conventional Oncology with Naturopathic Oncologist, Sonia Malani, ND, FABNO
Psychedelics for Brain Injury: A Mini-Review
New Chapter in Routledge Handbook on the Emerging Integrative Public Health Approach Published
Congratulations to Dr. Malani!
The Bluntness Interview
Can Psychedelics Help Make Dying Easier?
AIMS Co-Director Dr. Sunil Aggarwal Featured on the show The Edge on The Bluntness
Senior AIMS Institute Resident Physician Dr. Julianna Giles presents at the the 2021 Oncology Association of Naturopathic Physicians (OncANP) 10th Annual Conference
Cannabis makes gains in the medical community
Advancing Integrative Medical Care
Curt’s Cannabis Corner: Conversation with “Cannabinologist” Dr. Sunil Kumar Aggarwal
8 States Side With Cancer Patients In Psilocybin Lawsuit Against DEA
“This is an important time in public health in this country”
The Cannabis Summit 2020 – More Than Essential
We found this article and artistic rendition provocative and important.
2021 Virtual Cancer Wellness School
We need patient stories
Show #111 – Psychedelic Medicine
AIMS Co-Director Dr. Standish is presenting on a panel at…
Awesome medicine: Entheogenic integrative care for relief of spiritual and existential suffering in serious and chronic health conditions, trauma, and beyond
Measuring Cannabis’s Impact on Psychomotor Performance with the DRUID App
Save The Date: Bringing Psychedelic medicine, including Ayahuasca Tea, into the American health care system
Psychedelics for medical purposes: time to change your mind?
Latest in AIMS Psilocybin Right-To-Try Effort
Psychedelics: Part 2 – Sound Bite
Psilocybin Therapy
Cannabis and Cancer at this US Federal Heath research agency
Two-Track Effort To Allow Psychedelic Mushrooms In Washington State Launches Amid Broader Drug Decrim Push
This Seattle Doctor Is Using Psychedelics to Treat Cancer, Anxiety, Depression and PTSD
Magic mushrooms for Washington patients? New push aims to speed psilocybin to those who are dying
Seattle Hempfest 2020 – Cannabis, Entheogens, and Public Spiritual Health
November News
Integrating Cannabis into End-of-Life Care
Cannabis and the endocannabinoid system support
The Immortality Key: The Secret History of the Religion with No Name
Ketamine Assisted Psychotherapy (KAP)-Experiential Training for Providers
Magic Mushrooms and the Future of Psychology
Mahan Health Podcast – Dr. Standish
Latest Blog Posts
AIMS INSTITUTE’S COGNITIVE DECLINE PROTOCOL
LJ STANDISH AND DAVID JAMES Dr. Standish and her team can help improve brain function, improve memory and slow cognitive decline in Alzheimer’s disease. Please make an appointment to start. Call 206-420-1321. Scientific Rationale A protocol incorporating low-dose lithium orotate, Lion’s Mane mushroom extract, NADH, transcranial magnetic stimulation (TMS), and blood sugar regulation counseling is scientifically rational for treating cognitive decline based on mechanistic, preclinical, and emerging human studies. Low-Dose Lithium Orotate (5 mg/day) Recent brain tissue studies link low brain lithium to the onset and progression of Alzheimer’s disease, with deficiency accelerating synaptic loss and cognitive decline. Low-dose lithium orotate has ...
One Doctor’s Campaign to Let the Dying Take Psychedelics
Psilocybin mushrooms on a dehydrator tray. Photographer: Jason Connolly/AFP/Getty Images By Charles Gorrivan September 3, 2025 at 3:00 AM PDT Corrected September 3, 2025 at 9:04 AM PDT Hi, it’s Charles in New York. When Brave New World author Aldous Huxley was on his deathbed in 1963, his wife injected him with two doses of LSD, the powerful psychedelic, as he slipped away. Was Huxley on to something? More on that in a moment, but first … Today’s must-reads RFK Jr. set new priorities for the CDC after firing its director. A big Danish pension fund bets that Novo Nordisk ...